News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ViRexx Medical Corp. Announces Change In Board And 13D Filing
February 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
EDMONTON, ALBERTA -- (MARKET WIRE) -- February 16, 2007 -- ViRexx Medical Corp. ('ViRexx")(TSX: VIR)(AMEX: REX), announced today effective February 15, 2007, Michael Marcus of Austin, Texas, resigned from the Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
IPO tracker
Kardigan stitches up $369M IPO plan
June 11, 2026
·
16 min read
·
Editorial Team
Funding
SonoThera bags $125M series B to advance safer gene therapies
June 11, 2026
·
2 min read
·
Tristan Manalac
Job Trends
May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech
June 11, 2026
·
3 min read
·
Angela Gabriel
IPO
Update: Parabilis raises industry-record $670M IPO
June 10, 2026
·
2 min read
·
Gabrielle Masson